ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,560,618, issued on Feb. 24, was assigned to University of Miami (Miami).
"Innate immune proteins as biomarkers for CNS injury" was invented by Robert W. Keane (Miami), W. Dalton Dietrich (Miami), Juan Pablo De Rivero Vaccari (Miami), Stephanie Adamczak (Miami), M. Ross Bullock (Miami), Allan Levi (Miami) and Michael Y. Wang (Miami).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides novel markers of the severity of a central nervous system injury, such as spinal cord injury or traumatic brain injury, in a patient. In particular, protein components of inflammasomes in the cerebrospinal fluid that can be used to assess the severit...